Skip to main content

Herena Eixarch Ahufinger

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Herena Eixarch Ahufinger

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Unitat de Neuroimmunologia Clínica (UNiC)

IP: Unitat de Neuroimmunologia Clínica (UNiC)
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Unitat de Neuroimmunologia Clínica (UNiC), Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Unitat de Neuroimmunologia Clínica (UNiC), Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Unitat de Neuroimmunologia Clínica (UNiC), M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo , Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 793
Duration: 01/01/2010 - 30/04/2014

REEM - Red Española de Esclerosis Múltiple

IP: REEM - Red Española de Esclerosis Múltiple
Collaborators: Carlos Nos Llopis, REEM - Red Española de Esclerosis Múltiple, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, REEM - Red Española de Esclerosis Múltiple, M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 364373.77
Reference: RD07/0060/0020
Duration: 01/01/2008 - 31/12/2014

Quimerismo molecular como inductor de tolerancia en la encefalomielitis autoinmune experimental: mecanismos y optimización

IP: -
Collaborators: Francisco Vidal Pérez, Herena Eixarch Ahufinger, Carmen Espejo Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 177310
Reference: PI051441
Duration: 01/01/2006 - 31/12/2009

Concerted safety & efficiency evaluation of retroviral transgenesis in gene therapy of inherited diseases. Acronym: CONCERT FP6, Integrated Project Contract No 005242 LSHB-CT-2004-005242

IP: -
Collaborators: Herena Eixarch Ahufinger
Funding agency: EUROPEAN COMMISSION
Funding: 307500
Reference: FP6-CONSERT-5242
Duration: 01/01/2005 - 01/01/2009

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Guillem Pons Barcons

Guillem Pons Barcons

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Cristina Dus Moll

Cristina Dus Moll

Predoctoral researcher
Maternal and Fetal Medicine
Read more
Miriam Barrecheguren Fernández

Miriam Barrecheguren Fernández

Main researcher
Pneumology
Read more
Luz Maria Castro Reyes

Luz Maria Castro Reyes

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.